Clinical trial
A Phase 1/2 Study of SC-43 in Combination With Cisplatin
NCT04733521
Study timeline
Study start (estimated)2021-05-01Date precision: day
Registry last updated2021-02-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Advanced Non-small-cell Lung Cancerunresolved
Advanced Biliary Tract Cancerunresolved
Interventions
SC-43DRUG
CisplatinDRUG · verified · RxNorm: cisplatin
Sponsors & collaborators
RaND Bioscienceslead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04733521 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.